title: American Gastroenterological Association Institute Guideline on the pharmacological management of irritable bowel syndrome.
authors.affiliation: Fox Chase Cancer Center, Philadelphia, Pennsylvania.
authors.forename: David S
authors.initials: DS
authors.lastname: Weinberg
authors.affiliation: VA Tennessee Valley Healthcare System, Vanderbilt University, Nashville, Tennessee.
authors.forename: Walter
authors.initials: W
authors.lastname: Smalley
authors.affiliation: University of Michigan Ann Arbor, Michigan.
authors.forename: Joel J
authors.initials: JJ
authors.lastname: Heidelbaugh
authors.affiliation: Department of Veterans Affairs Medical Center, Gastroenterology Section, North Florida/South Georgia Veterans Health System, Division of Gastroenterology, Hepatology, and Nutrition, University of Florida, Gainesville, Florida; Minneapolis Veterans Affairs Health System, University of Minnesota, Minneapolis, Minnesota.
authors.forename: Shahnaz
authors.initials: S
authors.lastname: Sultan
mesh_terms: D003248:Constipation / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D016527:Drug Costs; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine / Q000592:standards; D005762:Gastroenterology / Q000191:economics / Q000592:standards*; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics; D016896:Treatment Outcome; D014481:United States
chemical_list: D005765:Gastrointestinal Agents